Publications Julia Hess
Fleischmann, D.F. ; Unger, K. ; Ruf, V. ; Heider, T. ; Hess J. ; Drexler, G. ; Herms, J. ; Thon, N. ; Kreth, F.-. ; Tonn, J.-. ; Zitzelsberger, H. ; Lauber, K. ; Belka, C. ; Niyazi, M.
Risk Stratification of Glioblastoma Patients using Blood Plasma Samples.Schmidt-Hegemann, N.-S. ; Hess J. ; Unger, K. ; Link, V. ; Buchner, A. ; Eze, C. ; Li, M. ; Stief, C. ; Kirchner, T. ; Ganswindt, U. ; Zitzelsberger, H. ; Belka, C.
DNA copy number and DNA methylome analysis of primary prostate cancer and pathologic lymph node metastases in patients with low and high Gleason score.Hansel, C. ; Wiesemann, A. ; Lauber, K. ; Hess J. ; Unger, K. ; Zitzelsberger, H. ; Jendrossek, V. ; Klein, D.
Radiation-induced senescence as potential target for normal tissue protection.Mutlu, S. ; Unger, K. ; Brix, N. ; Heider, T. ; Maier, S. ; Branz, P. ; Hess J. ; Belka, C. ; Zitzelsberger, H. ; Lauber, K.
Intrinsic radioresistance and intra-tumoral heterogeneity in HNSCC.Drexler, G.A. ; Klymenko, O. ; Baumeister, P. ; Weber, P. ; Heider, T. ; Selmansberger, M. ; Zitzelsberger, H. ; Unger, K. ; Hess J. ; Schoetz, U. ; Belka, C. ; Lauber, K.
Patient-derived HNSCC cell lines and subclones reflect inter- and intra-tumoral heterogeneity regarding various molecular and phenotypic aspects.Unger, K. ; Fleischmann, D.F. ; Ruf, V. ; Felsberg, J. ; Piehlmaier, D. ; Samaga, D. ; Hess J. ; Suresh, M.P. ; Mittelbronn, M. ; Lauber, K. ; Budach, W. ; Säbel, M. ; Rödel, C. ; Reifenberger, G. ; Herms, J. ; Tonn, J.C. ; Zitzelsberger, H. ; Belka, C. ; Niyazi, M.
Improved risk stratification in younger IDH wild-type glioblastoma patients by combining a 4-miRNA signature with MGMT promoter methylation status.Selmansberger, M. ; Michna, A. ; Braselmann, H. ; Höfig, I. ; Schorpp, K.K. ; Weber, P. ; Anastasov, N. ; Zitzelsberger, H. ; Hess J. ; Unger, K.
Transcriptome network of the papillary thyroid carcinoma radiation marker CLIP2.Samaga, D. ; Hornung, R. ; Braselmann, H. ; Hess J. ; Zitzelsberger, H. ; Belka, C. ; Boulesteix, A.L. ; Unger, K.
Single-center versus multi-center data sets for molecular prognostic modeling: A simulation study.Schüttrumpf, L. ; Marschner, S. ; Scheu, K. ; Hess J. ; Rietzler, S. ; Walch, A.K. ; Baumeister, P. ; Kirchner, T. ; Ganswindt, U. ; Zitzelsberger, H. ; Belka, C. ; Maihoefer, C.
Definitive chemoradiotherapy in patients with squamous cell cancers of the head and neck-results from an unselected cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer".Unger, K. ; Fleischmann, D.F. ; Ruf, V. ; Felsberg, J. ; Piehlmaier, D. ; Samaga, D. ; Hess J. ; Mittelbronn, M. ; Lauber, K. ; Budach, W. ; Säbel, M. ; Rödel, C. ; Reifenberger, G. ; Herms, J. ; Tonn, J.C. ; Zitzelsberger, H. ; Belka, C. ; Niyazi, M.
4-miRNA signature and MGMT promoter methylation improve risk stratisfaction in glioblastoma.Steens, J. ; Unger, K. ; Klar, L. ; Neureiter, A. ; Wieber, K. ; Hess J. ; Jakob, H.G. ; Klump, H. ; Klein, D.
Direct conversion of human fibroblasts into therapeutically active vascular wall-typical mesenchymal stem cells.